Late TGA run sees success for BI, Janssen

By Megan Brodie 1 year ago | In Products, Regulatory
  • 1 year ago

21 December 2022 The TGA has approved a label expansion for Boehringer Ingelheim’s JARDIANCE (empagliflozin),…

This is subscriber-only content. Please login to continue reading.